Coral Laboratories Ltd. Share Price & Stock Analysis

Coral Laboratories Ltd. (BSE: 524506) is a Mumbai, Maharashtra-based company in the Medicinal Chemicals and Botanical Products industry. With a market capitalisation of ₹189 Cr, it ranks #2,697 by market cap among the 6,197 Indian listed companies on FinBizNet, and #57 of 86 in Medicinal Chemicals and Botanical Products. At ₹524.00 (as of 16 Nov 2026), the share price is 22.8% below its 52-week high of ₹679.00 and 45.6% above its 52-week low of ₹360.00. The share price is up 7.8% over one year and down 5.7% over three months.

Key Metrics

Current Price₹524.00
Market Cap₹189 Cr
BSE Code524506
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Medicinal Chemicals and Botanical Products
P/E Ratio11.4
Return on Equity7.98%
Return on Assets3.58%
52-Week Range₹360.00 – ₹679.00
1-Year Price Change+7.8%
3-Month Price Change-5.7%
Beta (1Y)0.41
Dividend Yield0.38%
HeadquartersMumbai, Maharashtra
Websitecorallab.com

Latest Quarterly Results — Q1 FY27

Revenue₹30 Cr
Net Profit₹5 Cr
Net Margin18.2%
EPS (Basic)₹15.08
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Coral Laboratories Ltd. Quarterly Revenue and Profit Trend

Coral Laboratories Ltd. reported revenue of ₹30 Cr in Q1 FY27, up 57.4% from ₹19 Cr in Q1 FY26 and up 11.9% from ₹26 Cr in Q4 FY26. It posted a net profit of ₹5 Cr for the quarter, against a net profit of ₹3 Cr in Q1 FY26 (up 110.5%). Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹19 Cr (Q1 FY26) to ₹32 Cr (Q2 FY25). The company was profitable in each of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹30 Cr₹5 Cr18.2%
Q4 FY26₹26 Cr₹5 Cr19.7%
Q3 FY26₹22 Cr₹3 Cr12.9%
Q2 FY26₹19 Cr₹6 Cr30.6%
Q1 FY26₹19 Cr₹3 Cr13.6%
Q4 FY25₹28 Cr₹3 Cr10.1%
Q3 FY25₹23 Cr₹6 Cr26.7%
Q2 FY25₹32 Cr₹6 Cr19.8%

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 74.96% of Coral Laboratories Ltd.'s shares as of Mar 2026, against 75.00% in Mar 2025 (−0.04 percentage points). Delivery averaged 79.2% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Coral Laboratories Ltd.

Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally. The company offers non-sterile products, including antibiotics/antibacterial, antifungal, gastro-intestinal drugs, antiemetic, analgesics/antipyretic/anti-inflammatory, antispasmodic, muscle relaxants, cough suppressant/expectorant, anticold, antiallergic, anti-asthmatic, cardiovascular medicines, anti-diabetic, anthelmentic, anti-protozoal/anti-amebic, antimalarial drugs, antipsychotic drugs, and thyroid products; topical, oral antiseptic, and calcium preparations; mouthwashes; nutritional, protein, and iron supplements; kits; appetizers; and other products. It also provides sterile products, such as small volume liquid, cephalosporin, betalactam, and lyophilized injectables; eye, ear, and nose drops; nasal sprays and metered dose inhalers; and large volume parenteral. In addition, the company offers various nutraceutical products, such as dietary supplements, herbal/

Products and Services

1. Formulations-This segment manufactures and sells pharmaceutical formulations.

Business Segments

1. Pharmaceutical Formulations-100%

Coral Laboratories Ltd. vs Peers — Medicinal Chemicals and Botanical Products

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Sun Pharmaceutical Industries Limited₹4,56,425 Cr39.514.72%₹16,199 Cr+11.2%
Laurus Labs Ltd₹1,31,242 Cr145.617.74%₹2,206 Cr+146.8%
Zydus Lifesciences Ltd₹1,19,651 Cr24.118.32%₹7,910 Cr+26.0%
Dr.Reddys Lab₹1,15,464 Cr26.911.52%₹8,698 Cr+14.5%
Cipla Limited₹1,14,712 Cr29.311.74%₹7,404 Cr-7.6%
Mankind Pharma₹1,09,870 Cr5712.45%₹4,338 Cr+16.7%
Aurobindo Pharma Ltd.₹1,05,150 Cr309.93%₹10,263 Cr+59.8%
Lupin Ltd₹92,087 Cr17.326.91%₹7,827 Cr+0.4%
Coral Laboratories Ltd.₹189 Cr11.47.98%₹30 Cr+7.8%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Coral Laboratories Ltd.?

Coral Laboratories Ltd. is trading at ₹524.00, with a market capitalisation of ₹189 Cr.

Which sector does Coral Laboratories Ltd. belong to?

Coral Laboratories Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Medicinal Chemicals and Botanical Products).

What are the key financial ratios of Coral Laboratories Ltd.?

Coral Laboratories Ltd. has a P/E of 11.4 and a return on equity of 7.98%.

What is the stock symbol of Coral Laboratories Ltd.?

Coral Laboratories Ltd. is listed on the BSE under the scrip code 524506.

How has Coral Laboratories Ltd.'s share price moved over the past year?

Coral Laboratories Ltd.'s share price is up 7.8% over one year and down 5.7% over three months. Its 52-week range is ₹360.00 to ₹679.00.

What were Coral Laboratories Ltd.'s latest quarterly results?

In Q1 FY27, Coral Laboratories Ltd. reported revenue of ₹30 Cr and net profit of ₹5 Cr, with basic EPS of ₹15.08 (standalone, parsed from the company's exchange filing).

How have Coral Laboratories Ltd.'s revenue and profit changed over the past year?

Coral Laboratories Ltd. reported revenue of ₹30 Cr in Q1 FY27, up 57.4% from ₹19 Cr in Q1 FY26 and up 11.9% from ₹26 Cr in Q4 FY26.

What is the promoter holding in Coral Laboratories Ltd.?

Promoters held 74.96% of Coral Laboratories Ltd.'s shares as of Mar 2026, against 75.00% in Mar 2025 (−0.04 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.